Product Specifications
| Specification | Details |
| Manufacturer / Brand | Fresenius Kabi USA, LLC / Xylocaine® |
| Manufacturer # / SKU | 63323048257 |
| NDC Number | 63323-0482-57 |
| Active Ingredients | Lidocaine Hydrochloride (10 mg/mL) / Epinephrine (0.01 mg/mL) |
| Strength / Ratio | 1% Lidocaine HCl with Epinephrine 1:100,000 |
| Volume per Unit | 50 mL |
| Container Type | Multiple-Dose Vial (MDV) |
| Formulation | Contains Methylparaben Preservative & Sodium Metabisulfite |
| Storage Temperature | 20°C to 25°C (68°F to 77°F) |
| Packaging | Each / Box (25 Vials/EA) |
| Latex Content | Not made with natural rubber latex |
Key Features & Clinical Applications
-
Dual-Action Efficacy: Epinephrine causes localized vasoconstriction, which slows systemic absorption, extends the anesthetic block window, and minimizes localized bleeding.
-
Red Color Coded: Visual identification features a bright red flip-top cap to help healthcare workers instantly identify the concentration and presence of epinephrine.
-
Preserved Formulation: Contains 1 mg/mL of methylparaben to prevent microbial growth across multiple needle punctures.
-
Extended Volume: The 50 mL vial capacity supports extensive infiltration blocks, large field blocks, or multiple small procedures within an active clinic day.
-
Clinical Use: Highly utilized for local dermal infiltration, minor dermatological excisions, dental procedures, and peripheral nerve blocks.
⚠️ Usage Note: Do Not Autoclave. Because this formulation contains epinephrine, autoclaving will cause chemical degradation of the vasoconstrictor. Protect from light.
⚠️ Contraindications: Do not use if the solution turns a pinkish hue, darkens beyond a very light yellow, or develops a visible precipitate.
⚠️ Anatomical Warning: Use extreme caution when infiltrating areas supplied by end-arteries (e.g., fingers, toes, nose, ears, penis), as vasoconstriction from epinephrine can cause localized tissue ischemia or necrosis.
